increased length of allograft survival_Fgl2<tm1Pam>/Fgl2<tm1Pam>

http://metadb.riken.jp/0004751I129X1SvJC57BL6JFgl2tm1PamFgl2tm1PamFgl2tm1Pam

increased length of allograft survival_Fgl2<tm1Pam>/Fgl2<tm1Pam>

表現型アノテーション

MGI marker

http://metadb.riken.jp/db/mgi_rdf/variant_of

• fibrinogen-like protein 2
  http://metadb.riken.jp/db/mgi_rdf/MGI:103266

遺伝子型

http://metadb.riken.jp/db/mgi_rdf/allele_composition

• Fgl2<tm1Pam>/Fgl2<tm1Pam>

アレルシンボル

http://metadb.riken.jp/db/mgi_rdf/allele_symbol

• Fgl2<tm1Pam>

遺伝的背景

http://metadb.riken.jp/db/mgi_rdf/genetic_background

• involves: 129X1/SvJ * C57BL/6J

MP annotation

http://metadb.riken.jp/db/bioresource_schema/brs_indicatesPhenotype

• increased length of allograft survival
  http://purl.obolibrary.org/obo/MP_0004751

文献

http://purl.org/net/cito/citesAsAuthority

• Qin. Ning, et.al., Role of fibrinogen-like protein 2 prothrombinase/fibroleukin in experimental and human allograft rejection., Journal of immunology (Baltimore, Md. : 1950), 2005, 174
  http://rdf.ncbi.nlm.nih.gov/pubmed/15905589